Protein Kinase G from Pathogenic Mycobacteria Promotes Survival Within Macrophages DOI Open Access
Anne Walburger,

Anil Koul,

Giorgio Ferrari

и другие.

Science, Год журнала: 2004, Номер 304(5678), С. 1800 - 1804

Опубликована: Май 25, 2004

Pathogenic mycobacteria resist lysosomal delivery after uptake into macrophages, allowing them to survive intracellularly. We found that the eukaryotic-like serine/threonine protein kinase G from pathogenic was secreted within macrophage phagosomes, inhibiting phagosome-lysosome fusion and mediating intracellular survival of mycobacteria. Inactivation by gene disruption or chemical inhibition resulted in localization mycobacterial cell death infected macrophages. Besides identifying a target for control infections, these findings suggest have evolved signal transduction mechanisms capable modulating host trafficking pathways.

Язык: Английский

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides DOI
Christopher J. Phiel, Clare Wilson, Virginia M.‐Y. Lee

и другие.

Nature, Год журнала: 2003, Номер 423(6938), С. 435 - 439

Опубликована: Май 1, 2003

Язык: Английский

Процитировано

1160

A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules DOI Creative Commons
Laura A. Banaszynski,

Ling-chun Chen,

Lystranne A. Maynard-Smith

и другие.

Cell, Год журнала: 2006, Номер 126(5), С. 995 - 1004

Опубликована: Сен. 1, 2006

Язык: Английский

Процитировано

890

Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity DOI

Theonie Anastassiadis,

Sean Deacon,

Karthik Devarajan

и другие.

Nature Biotechnology, Год журнала: 2011, Номер 29(11), С. 1039 - 1045

Опубликована: Окт. 30, 2011

Язык: Английский

Процитировано

861

GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins DOI Creative Commons
Laurent Meijer,

Alexios-Leandros Skaltsounis,

Prokopios Magiatis

и другие.

Chemistry & Biology, Год журнала: 2003, Номер 10(12), С. 1255 - 1266

Опубликована: Дек. 1, 2003

Язык: Английский

Процитировано

799

GSK3 inhibitors: development and therapeutic potential DOI
Philip Cohen, Michel Goedert

Nature Reviews Drug Discovery, Год журнала: 2004, Номер 3(6), С. 479 - 487

Опубликована: Июнь 1, 2004

Язык: Английский

Процитировано

760

Systematic Discovery of In Vivo Phosphorylation Networks DOI Creative Commons
Rune Linding, Lars Juhl Jensen, Gerard J. Ostheimer

и другие.

Cell, Год журнала: 2007, Номер 129(7), С. 1415 - 1426

Опубликована: Июнь 1, 2007

Язык: Английский

Процитировано

739

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models withEGFRandERBB2Mutations that Are Resistant to Gefitinib DOI
Jeffrey A. Engelman,

Kreshnik Zejnullahu,

Christopher-Michael Gale

и другие.

Cancer Research, Год журнала: 2007, Номер 67(24), С. 11924 - 11932

Опубликована: Дек. 15, 2007

Abstract Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors gefitinib and erlotinib are effective treatments for a subset of non–small cell lung cancers. In particular, cancers with specific EGFR-activating mutations seem to be the most sensitive these agents. However, despite their initial response, such almost invariably develop resistance. 50% cancers, secondary EGFR mutation, T790M, has been identified that renders ineffective activity. Thus, there is clinical need novel can effectively inactivate T790M-containing proteins. this study, we evaluate effectiveness compound, PF00299804, an irreversible pan-ERBB inhibitor. The results from studies show PF00299804 potent inhibitor as well T790M resistance mutation both in vitro vivo. Additionally, highly wild-type ERBB2 gefitinib-resistant oncogenic These preclinical evaluations support further development and/or amplifications ERBB family members. [Cancer Res 2007;67(24):11924–32]

Язык: Английский

Процитировано

695

Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale DOI

Beth Rose,

Thomas Force, Yibin Wang

и другие.

Physiological Reviews, Год журнала: 2010, Номер 90(4), С. 1507 - 1546

Опубликована: Окт. 1, 2010

Among the myriad of intracellular signaling networks that govern cardiac development and pathogenesis, mitogen-activated protein kinases (MAPKs) are prominent players have been focus extensive investigations in past decades. The four best characterized MAPK subfamilies, ERK1/2, JNK, p38, ERK5, targets pharmacological genetic manipulations to uncover their roles development, function, diseases. However, information reported literature from these efforts has not yet resulted a clear view about specific pathways heart. Rather, controversies contradictive results led perception MAPKs ambiguous characters heart with both protective detrimental effects. primary object this review is provide comprehensive overview current progress, an effort highlight areas where consensus established verses ones controversy remains. hypertrophy, ischemia/reperfusion injury, pathological remodeling main focuses as represent most critical issues for evaluating viable therapeutic development. studies presented will help reveal major challenges field limitations approaches point need future gain better understanding fundamental mechanisms function regulation

Язык: Английский

Процитировано

685

LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β DOI Creative Commons
Stéphane Peineau, Changiz Taghibiglou, Clarrisa A. Bradley

и другие.

Neuron, Год журнала: 2007, Номер 53(5), С. 703 - 717

Опубликована: Март 1, 2007

Язык: Английский

Процитировано

666

Redox regulation of FoxO transcription factors DOI Creative Commons
Lars‐Oliver Klotz, Cristina Sánchez‐Ramos, Ignacio Priéto

и другие.

Redox Biology, Год журнала: 2015, Номер 6, С. 51 - 72

Опубликована: Июль 5, 2015

Transcription factors of the forkhead box, class O (FoxO) family are important regulators cellular stress response and promote antioxidant defense. On one hand, FoxOs stimulate transcription genes coding for proteins located in different subcellular compartments, such as mitochondria (i.e. superoxide dismutase-2, peroxiredoxins 3 5) peroxisomes (catalase), well found extracellularly plasma (e.g., selenoprotein P ceruloplasmin). other reactive oxygen species (ROS) stressful stimuli that elicit formation ROS, may modulate FoxO activity at multiple levels, including posttranslational modifications (such phosphorylation acetylation), interaction with coregulators, alterations localization, protein synthesis stability. Moreover, transcriptional posttranscriptional control expression is sensitive to ROS. Here, we review these aspects biology focusing on redox regulation signaling, emphasis interplay between ROS under various physiological pathophysiological conditions. Of particular interest dual role played by cancer development their key whole body nutrient homeostasis, modulating metabolic adaptations and/or disturbances low vs. high intake. Examples discussed here include calorie restriction starvation adipogenesis, obesity type 2 diabetes.

Язык: Английский

Процитировано

664